Skip to main content

Advertisement

SpringerLink
Log in

The role of endocrine treatment on the risk of developing an ipsilateral invasive breast cancer in hormone receptor positive patients with ductal carcinoma in situ

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Alaeikhanehshir S, Schmitz RSJM, van den Belt-Dusebout AW et al (2023) The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-023-07168-8

    Article  PubMed  Google Scholar 

  2. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717

    Article  Google Scholar 

  3. Wapnir IL, Dignam JJ, Fisher B et al (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103:478–488

    Article  PubMed  PubMed Central  Google Scholar 

  4. Allred DC, Bryant J, Land S et al (2022) Estrogen receptor expression as a predictive marker of the effectiveness of tamoxifen in the treatment of DCIS: findings from the NSABP protocol B-24 [abstract]. Breast Cancer Res Treat 76(Suppl 1):A30

    Google Scholar 

  5. Lazzeroni M, Puntoni M, Guerrieri-Gonzaga A et al (2023) Randomized placebo controlled trial of low-dose tamoxifen to prevent recurrence in breast noninvasive neoplasia: a 10-year follow-up of TAM-01 study. J Clin Oncol 41(17):3116–3121

    Article  CAS  PubMed  Google Scholar 

  6. Forbes JF, Sestak I, Howell A et al (2016) Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial. Lancet 387(10021):866–873

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Margolese RG, Cecchini RS, Julian TB et al (2016) Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Lancet 387(10021):849–856

    Article  CAS  PubMed  Google Scholar 

  8. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 17 Nov 2023

Download references

Funding

No funding.

Author information

Authors and Affiliations

  1. MKA Breast Cancer Clinic, Tepe Prime, 06800, Cankaya, Ankara, Turkey

    Kadri Altundag

Authors
  1. Kadri Altundag
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kadri Altundag.

Ethics declarations

Conflict of interest

We declare that I have no conflict of interest.

Ethical approval

Not applicable.

Informed consent

Not applicable.

Research involving human and animal participants

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Altundag, K. The role of endocrine treatment on the risk of developing an ipsilateral invasive breast cancer in hormone receptor positive patients with ductal carcinoma in situ. Breast Cancer Res Treat 204, 189–190 (2024). https://doi.org/10.1007/s10549-023-07212-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-023-07212-7

Search

Navigation